Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35


Cancer cachexia in thoracic malignancy: a narrative review.

Kidd AC, Skrzypski M, Jamal-Hanjani M, Blyth KG.

Curr Opin Support Palliat Care. 2019 Oct 4. doi: 10.1097/SPC.0000000000000465. [Epub ahead of print]


Inter-observer variation in image interpretation and the prognostic importance of non-expansile lung in malignant pleural effusion.

Martin GA, Kidd AC, Tsim S, Halford P, Bibby A, Maskell NA, Blyth KG.

Respirology. 2019 Aug 21. doi: 10.1111/resp.13681. [Epub ahead of print]


Pre-EDIT: A Randomized Feasibility Trial of Elastance-Directed Intrapleural Catheter or Talc Pleurodesis in Malignant Pleural Effusion.

Martin GA, Tsim S, Kidd AC, Foster JE, McLoone P, Chalmers A, Blyth KG.

Chest. 2019 Jul 30. pii: S0012-3692(19)31384-4. doi: 10.1016/j.chest.2019.07.010. [Epub ahead of print]


Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups.

Tsim S, Paterson S, Cartwright D, Fong CJ, Alexander L, Kelly C, Holme J, Evison M, Blyth KG.

Lung Cancer. 2019 Jul;133:123-129. doi: 10.1016/j.lungcan.2019.05.017. Epub 2019 May 16.


Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.

Armato SG 3rd, Francis RJ, Katz SI, Ak G, Opitz I, Gudmundsson E, Blyth KG, Gupta A.

Lung Cancer. 2019 Apr;130:108-114. doi: 10.1016/j.lungcan.2018.11.033. Epub 2018 Nov 28. Review.


Lung cancer symptom appraisal among people with chronic obstructive pulmonary disease: A qualitative interview study.

Cunningham Y, Wyke S, Blyth KG, Rigg D, Macdonald S, Macleod U, Harrow S, Robb KA, Whitaker KL.

Psychooncology. 2019 Apr;28(4):718-725. doi: 10.1002/pon.5005. Epub 2019 Feb 12.


Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The development and validation of the LNC-PATH score.

Balata H, Foden P, Edwards T, Chaturvedi A, Elshafi M, Tempowski A, Teng B, Whittemore P, Blyth KG, Kidd A, Ellames D, Flint LA, Robson J, Teh E, Jones R, Batchelor T, Crosbie P, Booton R, Evison M.

Lung Cancer. 2018 Nov;125:29-34. doi: 10.1016/j.lungcan.2018.08.026. Epub 2018 Aug 31.


Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme.

Lindsay CR, Shaw EC, Blackhall F, Blyth KG, Brenton JD, Chaturvedi A, Clarke N, Dick C, Evans TRJ, Hall G, Hanby AM, Harrison DJ, Johnston SRD, Mason MD, Morton D, Newton-Bishop J, Nicholson AG, Oien KA, Popat S, Rassl D, Sharpe R, Taniere P, Walker I, Wallace WA, West NP, Butler R, Gonzalez de Castro D, Griffiths M, Johnson PWM.

ESMO Open. 2018 Sep 5;3(6):e000408. doi: 10.1136/esmoopen-2018-000408. eCollection 2018.


Providing safe and effective pleural medicine services in the UK: an aspirational statement from UK pleural physicians.

Evison M, Blyth KG, Bhatnagar R, Corcoran J, Saba T, Duncan T, Hallifax R, Ahmed L, West A, Pepperell JCT, Roberts M, Sivasothy P, Psallidas I, Clive AO, Latham J, Stanton AE, Maskell N, Rahman N.

BMJ Open Respir Res. 2018 Aug 3;5(1):e000307. doi: 10.1136/bmjresp-2018-000307. eCollection 2018.


An Inconvenient Truth Concerning Surgery for Mesothelioma.

de Fonseka D, Slade M, Blyth KG, Edwards J, Evison M, Roberts M, Rahman N, Woolhouse I, Maskell NA.

J Clin Oncol. 2018 Sep 10;36(26):2745-2746. doi: 10.1200/JCO.2018.78.6590. Epub 2018 Jun 14. No abstract available.


Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion.

Martin GA, Tsim S, Kidd AC, Foster JE, McLoone P, Chalmers A, Blyth KG.

BMJ Open Respir Res. 2018 May 29;5(1):e000293. doi: 10.1136/bmjresp-2018-000293. eCollection 2018.


Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy.

Tsim S, Humphreys CA, Cowell GW, Stobo DB, Noble C, Woodward R, Kelly CA, Alexander L, Foster JE, Dick C, Blyth KG.

Lung Cancer. 2018 Apr;118:48-56. doi: 10.1016/j.lungcan.2018.01.014. Epub 2018 Feb 3.


Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors.

Kidd AC, McGettrick M, Tsim S, Halligan DL, Bylesjo M, Blyth KG.

BMJ Open Respir Res. 2018 Jan 30;5(1):e000240. doi: 10.1136/bmjresp-2017-000240. eCollection 2018.


Progress and challenges in Mesothelioma: From bench to bedside.

Blyth KG, Murphy DJ.

Respir Med. 2018 Jan;134:31-41. doi: 10.1016/j.rmed.2017.11.015. Epub 2017 Nov 26. Review.


A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.

Haughney J, Morice A, Blyth KG, Lee AJ, Coutts A, McKnight E, Pavord I.

Respir Med. 2018 Jan;134:117-123. doi: 10.1016/j.rmed.2017.12.001. Epub 2017 Dec 5.


Estimating past inhalation exposure to asbestos: A tool for risk attribution and disease screening.

Cherrie JW, McElvenny D, Blyth KG.

Int J Hyg Environ Health. 2018 Jan;221(1):27-32. doi: 10.1016/j.ijheh.2017.09.013. Epub 2017 Oct 7.


Empyema necessitans and a persistent air leak associated with rupture of an anaerobic lung abscess due to bacteroides.

Sharma V, Blyth KG.

Thorax. 2018 Jan;73(1):91-93. doi: 10.1136/thoraxjnl-2017-210462. Epub 2017 Aug 28. No abstract available. Erratum in: Thorax. 2018 Apr;73(4):404.


Predicting lung cancer recurrence from circulating tumour DNA. Commentary on 'Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution'.

Murphy DJ, Blyth KG.

Cell Death Differ. 2017 Sep;24(9):1473-1474. doi: 10.1038/cdd.2017.97. Epub 2017 Jun 16. No abstract available.


Dobutamine stress MRI in pulmonary hypertension: relationships between stress pulmonary artery relative area change, RV performance, and 10-year survival.

Blyth KG, Bellofiore A, Jayasekera G, Foster JE, Steedman T, Chesler NC, Peacock AJ.

Pulm Circ. 2017 Apr-Jun;7(2):465-475. doi: 10.1177/2045893217704838. Epub 2017 Mar 27.


Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.

Popowicz N, Bintcliffe O, De Fonseka D, Blyth KG, Smith NA, Piccolo F, Martin G, Wong D, Edey A, Maskell N, Lee YCG.

Ann Am Thorac Soc. 2017 Jun;14(6):929-936. doi: 10.1513/AnnalsATS.201609-673OC.


The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy.

Tsim S, Stobo DB, Alexander L, Kelly C, Blyth KG.

Lung Cancer. 2017 Jan;103:38-43. doi: 10.1016/j.lungcan.2016.11.010. Epub 2016 Nov 18.


Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.

Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG, Maskell NA, Psallidas I.

Eur Respir Rev. 2016 Dec;25(142):472-486. doi: 10.1183/16000617.0063-2016. Review.


Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study.

Tsim S, Kelly C, Alexander L, McCormick C, Thomson F, Woodward R, Foster JE, Stobo DB, Paul J, Maskell NA, Chalmers A, Blyth KG.

BMJ Open. 2016 Nov 24;6(11):e013324. doi: 10.1136/bmjopen-2016-013324.


Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group.

Armato SG 3rd, Blyth KG, Keating JJ, Katz S, Tsim S, Coolen J, Gudmundsson E, Opitz I, Nowak AK.

Lung Cancer. 2016 Nov;101:48-58. doi: 10.1016/j.lungcan.2016.09.003. Epub 2016 Sep 5. Review.


Rescue therapy using an endobronchial valve and digital air leak monitoring in Invasive Pulmonary Aspergillosis.

Tsim S, Paton L, Nicholson F, Blyth KG.

Respir Med Case Rep. 2014 Dec 16;14:27-9. doi: 10.1016/j.rmcr.2014.12.001. eCollection 2015.


Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studies.

Blyth KG.

Thorax. 2015 Apr;70(4):374. doi: 10.1136/thoraxjnl-2014-206464. Epub 2014 Dec 5. No abstract available.


Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.

Piccolo F, Pitman N, Bhatnagar R, Popowicz N, Smith NA, Brockway B, Nickels R, Burke AJ, Wong CA, McCartney R, Choo-Kang B, Blyth KG, Maskell NA, Lee YC.

Ann Am Thorac Soc. 2014 Nov;11(9):1419-25. doi: 10.1513/AnnalsATS.201407-329OC.


Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study.

Peacock AJ, Crawley S, McLure L, Blyth KG, Vizza CD, Poscia R, Francone M, Iacucci I, Olschewski H, Kovacs G, Vonk Noordegraaf A, Marcus JT, van de Veerdonk MC, Oosterveer FP.

Circ Cardiovasc Imaging. 2014 Jan;7(1):107-14. doi: 10.1161/CIRCIMAGING.113.000629. Epub 2013 Oct 30. Erratum in: Circ Cardiovasc Imaging. 2017 Feb;10 (2):.


Quantitative estimation of right ventricular hypertrophy using ECG criteria in patients with pulmonary hypertension: A comparison with cardiac MRI.

Blyth KG, Kinsella J, Hakacova N, McLure LE, Siddiqui AM, Wagner GS, Peacock AJ.

Pulm Circ. 2011 Oct-Dec;1(4):470-4. doi: 10.4103/2045-8932.93546.


Assessment of the presence of occult myocardial infarction in chronic obstructive pulmonary disease using contrast-enhanced cardiac magnetic resonance imaging.

Murphy CA, Blyth KG, Chaudhuri R, Lafferty J, Hothersall E, Steedman T, McSharry C, Dargie HJ, Thomson NC.

Respiration. 2009;78(3):263-9. doi: 10.1159/000203354. Epub 2009 Feb 18.


Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease.

Mark PB, Doyle A, Blyth KG, Patel RK, Weir RA, Steedman T, Foster JE, Dargie HJ, Jardine AG.

J Cardiovasc Magn Reson. 2008 Aug 18;10:39. doi: 10.1186/1532-429X-10-39.


Pulmonary arterial pulse pressure and mortality in pulmonary arterial hypertension.

Blyth KG, Syyed R, Chalmers J, Foster JE, Saba T, Naeije R, Melot C, Peacock AJ.

Respir Med. 2007 Dec;101(12):2495-501. Epub 2007 Aug 24.


NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension.

Blyth KG, Groenning BA, Mark PB, Martin TN, Foster JE, Steedman T, Morton JJ, Dargie HJ, Peacock AJ.

Eur Respir J. 2007 Apr;29(4):737-44. Epub 2006 Nov 29.


Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.

Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, Steedman T, Dargie HJ, Jardine AG.

Kidney Int. 2006 May;69(10):1839-45.


Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension.

Blyth KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ, Peacock AJ.

Eur Heart J. 2005 Oct;26(19):1993-9. Epub 2005 May 17.


Supplemental Content

Loading ...
Support Center